Healthcare & Life Sciences
Inhibrx
United Statesinhibrx.com/
Inhibrx is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Inhibrx
Inhibrx is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Inhibrx is a clinical-stage biopharmaceutical company that designs and develops biologic therapeutics using a proprietary single-domain antibody and protein-engineering platform, advancing targeted immunotherapies for serious and life-threatening conditions.
Explore Inhibrx's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.